Skip to content

Clinical trials

Phase 1 Respiratory Tract Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Neoplasms Phase: Phase 1 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20162
20181
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Revolution Medicines, Inc.3
Syndax Pharmaceuticals3
H. Lee Moffitt Cancer Center and Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung10
Lung Diseases10
Lung Neoplasms10
Neoplasms10
Respiratory Tract Neoplasms10
Thoracic Neoplasms10
Bronchial Neoplasms9
Neoplasms by Site8
Respiratory Tract Diseases8
Carcinoma, Bronchogenic7

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.